$RGBP About Zander Therapeutics Inc.: Zande
Post# of 7739
Zander Therapeutics is a wholly-owned subsidiary of Entest BioMedical Inc. (ENTB), a publicly traded biotechnology company focused on veterinary medicine. The Company seeks to develop small molecule and immune stimulating therapies for veterinary application. Currently, the Company's major interest is in developing small molecule therapies for treating cancer and autoimmune diseases in animals, which include arthritis.
https://finance.yahoo.com/news/regen-biopharm...00603.html